Oral administration of erythromycin decreases RNA toxicity in myotonic dystrophy

by Nakamori, Masayuki, Taylor, Katarzyna, Mochizuki, Hideki, Sobczak, Krzysztof, Takahashi, Masanori P.
Published 2015

Small molecule kinase inhibitors alleviate different molecular features of myotonic dystrophy type 1

by Wojciechowska, Marzena, Taylor, Katarzyna, Sobczak, Krzysztof, Napierala, Marek, Krzyzosiak, Wlodzimierz J
Published 2014

Mechanistic determinants of MBNL activity

by Sznajder, Łukasz J., Michalak, Michał, Taylor, Katarzyna, Cywoniuk, Piotr, Kabza, Michał, Wojtkowiak-Szlachcic, Agnieszka, Matłoka, Magdalena, Konieczny, Patryk, Sobczak, Krzysztof
Published 2016

Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy

by Wojtkowiak-Szlachcic, Agnieszka, Taylor, Katarzyna, Stepniak-Konieczna, Ewa, Sznajder, Lukasz J., Mykowska, Agnieszka, Sroka, Joanna, Thornton, Charles A., Sobczak, Krzysztof
Published 2015